SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Renovar Regulatory News (MRV)

Share Price Information for Maven Renovar (MRV)

Share Price is delayed by 15 minutes
Get Live Data
53.25    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.50 (0.943%)
Market Cap: £68.50m
MRV Live PriceLast checked at - London Stock Exchange

Intraday Maven Renovar Share Chart

EGM Statement

12 Dec 2005 16:47

Murray VCT PLC12 December 2005 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTOAUSTRALIA, CANADA, JAPAN, OR THE UNITED STATES OF AMERICA. THIS ANNOUNCEMENTDOES NOT CONSTITUTE OR FORM PART OF AN OFFER TO SELL, PURCHASE, EXCHANGE ORSUBSCRIBE FOR ANY SECURITIES OR SOLICITATION OF SUCH AN OFFER IN THE UNITEDSTATES OF AMERICA OR ANY OTHER JURISDICTION. THE SECURITIES REFERRED TO IN THISANNOUNCEMENT HAVE NOT BEEN AND WILL NOT BE REGISTERED UNDER THE UNITED STATESSECURITIES ACT OF 1933, AS AMENDED, AND WILL NOT BE OFFERED OR SOLD IN THEUNITED STATES EXCEPT PURSUANT TO AN APPLICABLE EXEMPTION FROM REGISTRATION 12 December 2005 Murray VCT PLC (the "Company")Results of Annual General Meeting, Extraordinary General Meeting and CourtMeeting The Directors are pleased to announce that at the Extraordinary General Meetingand Court Meeting of the Company held today the resolutions proposed to effectthe merger of the Company with Murray VCT 2 PLC and Murray VCT 3 PLC by way of aScheme of Arrangement were passed. Shareholders also resolved to authorise the Company to make market purchases ofup to 2,832,137 Shares pursuant to the Tender Offer at the Tender Price. At the Annual General Meeting of the Company also held today the resolutions putforward by Mr Charles Clark to remove the Company's existing directors weredefeated. The normal business of the meeting was approved. The Directors further announce that Tenders in respect of 2,790,376 Shares weremade under the Tender Offer, representing 9.85 per cent. of the issued ordinaryshare capital. In accordance with the terms of the Tender Offer, the totalnumber of Shares to be bought back under the Tender Offer will therefore be2,790,376 Shares, representing 9.85 per cent. of the Shares in issue on theRecord Date. Accordingly, as a result of the aggregate level of Tenders,applications in excess of the Basic Entitlement will be satisfied as to 100 percent. Subject to approval of the Scheme at the Court hearing scheduled for 12 January2006, it is expected that the effective date of the merger will be 13 January2006. A further announcement, to include information on the formula asset valuecalculations and the Tender Price, will be made at this time. The definitions set out on pages 3 to 6 of the Company's Circular dated 18November 2005 shall, unless the context otherwise requires, bear the samemeanings in this announcement. Enquiries Patrick Reeve 020 7422 7830Emil Gigov 020 7422 7830Close Venture Management Limited Allan Treacy 01223 422 396AGM Corporate Finance LLP, advisersto the Company John West 020 7920 3150Clemmie CarrTavistock Communications The directors of the Company accept responsibility for the information relatingto the Company and its directors in this document. To the best of the knowledgeand belief of such directors (who have taken all reasonable care to ensure thatsuch is the case), the information relating to the Company and its directorscontained in this document, for which they are solely responsible, is inaccordance with the facts and does not omit anything likely to affect the importof such information. AGM Corporate Finance LLP is acting exclusively for the Company and for no oneelse in connection with the merger and will not be responsible to anyone otherthan the Company for providing the protections afforded to clients of AGMCorporate Finance LLP nor for providing advice in relation to the merger. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
12th Jun 20264:42 pmRNSUnaudited Net Asset Value
10th Jun 20265:02 pmRNSTransaction in Own Shares
8th Jun 20269:24 amRNSUnaudited Net Asset Value
4th Jun 20261:24 pmRNSTransaction in Own Shares
2nd Jun 202612:05 pmRNSUnaudited Net Asset Value
1st Jun 20267:00 amRNSTotal Voting Rights
29th May 20264:27 pmRNSTransaction in Own Shares
26th May 20261:50 pmRNSResult of Tender Offer
26th May 202611:29 amRNSUnaudited Net Asset Value
22nd May 202610:56 amRNSTransaction in Own Shares
20th May 20264:30 pmRNSAnnual Financial Report
20th May 20263:25 pmRNSResult of General Meeting
18th May 20262:52 pmRNSUnaudited Net Asset Value
14th May 202610:52 amRNSTransaction in Own Shares
11th May 202612:24 pmRNSUnaudited Net Asset Value
6th May 202612:54 pmRNSTransaction in Own Shares
1st May 20264:28 pmRNSUnaudited Net Asset Value
1st May 20267:00 amRNSTotal Voting Rights
27th Apr 20264:49 pmRNSUnaudited Net Asset Value
27th Apr 202610:02 amRNSPublication of Tender Offer Circular
23rd Apr 20262:12 pmRNSTransaction in Own Shares
17th Apr 20264:02 pmRNSUnaudited Net Asset Value
13th Apr 202612:36 pmRNSUnaudited Net Asset Value
2nd Apr 20269:02 amRNSUnaudited Net Asset Value
2nd Apr 20267:00 amRNSTender Offer
1st Apr 20267:00 amRNSTotal Voting Rights
30th Mar 20262:48 pmRNSTransaction in Own Shares
27th Mar 20264:17 pmRNSUnaudited NAV
27th Mar 20267:00 amRNSDividend Declaration
23rd Mar 202612:14 pmRNSUnaudited NAV
19th Mar 20264:14 pmRNSTransaction in Own Shares
18th Mar 20262:53 pmRNSCompliance with Market Abuse Regulation
16th Mar 20264:10 pmRNSUnaudited Net Asset Value
12th Mar 202611:49 amRNSTransaction in Own Shares
9th Mar 202612:37 pmRNSTransaction in Own Shares
9th Mar 202610:20 amRNSUnaudited Net Asset Value
3rd Mar 20261:01 pmRNSTransaction in Own Shares
2nd Mar 20265:18 pmRNSUnaudited Net Asset Value
23rd Feb 20263:53 pmRNSTransaction in Own Shares
23rd Feb 202610:35 amRNSUnaudited Net Asset Value
19th Feb 202612:05 pmRNSTransaction in Own Shares
13th Feb 20263:08 pmRNSUnaudited Net Asset Value
10th Feb 202612:15 pmRNSTransaction in Own Shares
10th Feb 202612:12 pmRNSStatement re Provision 5.2.4 of the AIC Code
6th Feb 20264:42 pmRNSUnaudited Net Asset Value
3rd Feb 20262:42 pmRNSTransaction in Own Shares
3rd Feb 202611:41 amRNSUnaudited Net Asset Value
2nd Feb 20267:00 amRNSChange of Company Secretary and Registered Office
2nd Feb 20267:00 amRNSTotal Voting Rights
30th Jan 20262:36 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.